These data indicate that Ccne1+ and Vgll3+ STS models recapitulate two distinct versions of the immune TME as found in the patients (“immune-excluded” vs. “immune-infiltrated”) and serve as unique tools for investigating molecular mechanisms behind immune exclusion and chemoresistance in sarcoma. This evidence concerns the gene VGLL3 and sarcoma.